Deficient Fumarylacetoacetate Fumarylhydrolase Activity in Lymphocytes and Fibroblasts from Patients with Hereditary Tyrosinemia
- 30 June 1983
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 17 (7) , 541-544
- https://doi.org/10.1203/00006450-198307000-00005
Abstract
Summary: Fumarylacetoacetate fumarylhydrolase (E.C.3.7.1.2.), a liver enzyme involved in tyrosine degradation, is shown to be present in many human tissues and cells including lymphocytes, fibroblasts, and cultured amniotic fluid cells. The enzyme activity in lymphocytes from six patients with hereditary tyrosinemia (hepatorenal type) and fibroblasts from three patients, was found to be less than 10% of the activity in control subjects. In lymphocytes and fibroblasts from the parents (n = 16) of the patients the enzyme values were compatible with a heterozygote genotype. The lymphocyte enzyme pattern of the control subjects (n = 97), is complicated, and indicates possible enzyme variants.Keywords
This publication has 6 references indexed in Scilit:
- Prenatal diagnosis of hereditary tyrosinaemia: Measurement of succinylacetone in amniotic fluidPrenatal Diagnosis, 1982
- Assay of fumarylacetoacetate fumarylhydrolase in human liver — deficient activity in a case of hereditary tyrosinemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Acute hereditary tyrosinaemia type I: Clinical, biochemical and haematological studies in twinsJournal of Inherited Metabolic Disease, 1980
- On the enzymic defects in hereditary tyrosinemia.Proceedings of the National Academy of Sciences, 1977
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951